DUBLIN, Oct. 31, 2023 /PRNewswire/ — The “Veterinary Dermatology Drugs Market Size, Share & Trends Analysis Report By Indication, By Type, By Animal Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 – 2030” report has been added to ResearchAndMarkets.com’s providing.
The international veterinary dermatology medication market is anticipated to achieve USD 28.69 billion by 2030, registering a CAGR of 8.89% from 2023 to 2030
The market is pushed by growing pet expenditure, humanization of pets, sturdy R&D pipeline, launch of recent merchandise, the prevalence of dermatologic situations, and initiatives by key firms.
For instance, in June 2023, Zoetis acquired FDA clearance for Apoquel Chewable – the nation’s first and solely chewable pharmaceutical for controlling allergic itch and irritation in dogs. This expanded the corporate’s portfolio and supported its development targets.
The COVID-19 pandemic and macroeconomic headwinds from 2020 to 2022 had each constructive and detrimental impacts available on the market. This included operational challenges, provide chain disruption, restricted access to veterinary care, spike in pet adoption, adoption of telemedicine, and elevated penetration of pet insurance coverage.
Vimian as an example, reported dampened development throughout Q1 2022 in its dermatology & specialty care segments resulting from volatility in shipments between quarters. By Q3 2022, the corporate reported sturdy development in Dermatology & Specialty Care segments. Zoetis then again witnessed quantity development of 14%, 3%, and 9% from in-line portfolio, together with its dermatology merchandise throughout Q2, Q3, and This autumn 2021 respectively. In 2022, nonetheless, Zoetis reported 1-2% quantity development in its dermatology portfolio each quarter.
Ongoing analysis and growth efforts within the area of veterinary dermatology have led to the creation of simpler and user-friendly drug formulations. These formulations are sometimes simpler to manage and may present faster aid for pets, guaranteeing remedy compliance.
Growing initiatives by key market gamers is anticipated to propel the R&D pipeline and promote the launch of recent merchandise available in the market. In May 2023, Dechra Pharmaceuticals PLC for instance, partnered with ILC Therapeutics in Scotland to analysis and develop the latter’s Caniferon product for the remedy of atopic dermatitis in dogs. This added to the corporate’s product pipeline.
Veterinary Dermatology Drugs Market Report Highlights
-
By indication, the parasitic infections phase dominated the market and held the biggest income share of greater than 40.0% in 2022 owing to growing strategic initiatives by key firms
-
For occasion, Virbac expanded its medicinal product line by buying the rights to plenty of early-stage parasiticides from Elanco in March 2021
-
The allergic infections phase is anticipated to witness the quickest CAGR of over 9.2% throughout the forecast interval
-
The prescription phase dominated the market in 2022, whereas, the OTC phase is anticipated to develop on the quickest CAGR of about 9.1% from 2023 to 2030
-
The companion animals dominated the market in 2022, as a result of rise in pet possession, public consciousness, and demand for high-quality animal care
-
The topical phase dominated the market in 2022 is anticipated to witness profitable CAGR throughout the forecast interval
-
By distribution channel, hospital pharmacies dominated the market with a income share of 62.0% in 2022
-
North America held the very best income share of over 38.0% of the market in 2022
Company Profiles
Key Topics Covered:
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Dermatology Drugs Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing Pet Ownership
3.2.1.2. Growing Number Of Clinical Trials Related To Veterinary Dermatology Drugs
3.2.1.3. Rising Incidence Rate Of Parasitic As Well As Other Skin Diseases In Animals
3.2.1.4. Investments By Market Players
3.2.2. Market Restraint Analysis
3.2.2.1. Lack Of Awareness In Developing Regions
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Veterinary Dermatology Drugs Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.2. PESTEL Analysis
3.3.3. Pricing Analysis
3.3.4. Clinical Trial Analysis
3.3.5. Estimated Animal Population, by key international locations, 2018 to 2022
3.3.6. COVID-19 Impact Analysis
Chapter 4. Veterinary Dermatology Drugs Market: Indication Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Dermatology Drugs Market: Indication Movement Analysis & Market Share, 2022 & 2030
4.3. Parasitic Infections
4.4. Allergic Infections
4.5. Others
Chapter 5. Veterinary Dermatology Drugs Market: Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Dermatology Drugs Market: Type Movement Analysis & Market Share, 2022 & 2030
5.3. Prescription
5.4. OTC
Chapter 6. Veterinary Dermatology Drugs Market: Animal sort Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Dermatology Drugs Market: Animal sort Movement Analysis & Market Share, 2022 & 2030
6.3. Companion Animals
6.3.1. Companion Animals Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.3.2. Dogs Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.3.3. Cats Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.3.4. Horses Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.3.5. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.4. Livestock Animals
6.4.1. Livestock Animals Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.4.2. Cattle Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
6.4.3. Others Market Revenue Estimates and Forecasts, 2018 – 2030 (USD Million)
Chapter 7. Veterinary Dermatology Drugs Market: Route of Administration Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Veterinary Dermatology Drugs Market: Route of Administration Movement Analysis & Market Share, 2022 & 2030
7.3. Topical
7.4. Oral
7.5. Injectable
Chapter 8. Veterinary Dermatology Drugs Market: Distribution Channel Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Veterinary Dermatology Drugs Market: Distribution Channel Movement Analysis & Market Share, 2022 & 2030
8.3. Hospital Pharmacies)
8.4. Retail
8.5. E-Commerce
Chapter 9. Veterinary Dermatology Drugs Market: Regional Estimates & Trend Analysis
9.1. Regional Outlook
9.2. Veterinary Dermatology Drugs Market: Regional Movement Analysis & Market Share, 2022 & 2030
Chapter 10. Competitive Landscape
10.1. Key Company Profiles
10.1.1. Participant’s Overview
10.1.2. Indication Benchmarking
10.1.3. Financial Performance
10.1.4. Strategic Initiatives
10.2. Participant Categorization
10.3. Heat Map Analysis/ Company Market Position Analysis
10.4. Strategy Mapping
10.5. List of Other Key Market Players
For extra details about this report go to https://www.researchandmarkets.com/r/6wfygc
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s main supply for worldwide market analysis reviews and market information. We give you the latest information on worldwide and regional markets, key industries, the highest firms, new merchandise and the latest tendencies.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outdoors U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View unique content material:https://www.prnewswire.com/news-releases/global-veterinary-dermatology-drugs-market-analysis-report-2023-market-to-reach-28-69-billion-by-2030—new-product-launches-and-robust-rd-pipeline-boosts-market-prospects-301972653.html
SOURCE Research and Markets